Literature DB >> 23846816

Association of the MTHFR C677T polymorphism with primary brain tumor risk.

Chen Xu1, Lutao Yuan, Hengli Tian, Heli Cao, Shiwen Chen.   

Abstract

Methylenetetrahydrofolate reductase (MTHFR) gene plays key roles not only in folate metabolism but also in carcinogenesis. The single nucleotide polymorphism MTHFR C677T has been indicated in the development of various tumors. The effect of the MTHFR C677T polymorphism on brain tumors remains poorly understood. We performed the present meta-analysis and aimed to provide a better understanding of the pathogenesis of brain tumors. A literature search of the PubMed, Embase, Web of Science, and Wanfang databases was carried out for potential relevant publications. We calculated the pooled odds ratio (OR) with corresponding 95% confidence interval (95% CI) to assess the association of MTHFR C677T with the susceptibility to brain tumors. We also performed stratified analysis and sensitivity analysis to further estimate the genetic association. All statistical analyses were conducted by the use of STATA 11.0 (STATA Corporation, College Station, TX, USA). Eight case-control studies involving a total of 3,059 cases and 3,324 controls were retrieved according to the inclusion criteria. The overall ORs suggested that the MTHFR C677T variant can exert a risk effect on brain tumor development under the following contrast models (OR(TC vs. CC) = 1.14, 95% CI 1.02-1.27, P OR = 0.018; OR(TT + TC vs. CC)= 1.23, 95% CI 1.01-1.51, P(OR) = 0.043). No significant correlation was identified among the Caucasians, but not among the Asians. In addition, the TC genotype carriers were more susceptible to meningioma when compared with the CC genotype carriers (OR(TC vs. CC) = 1.38, 95% CI 1.15-1.65, P(OR) < 0.001). The MTHFR C677T polymorphism seemed to exert no effect on glioma risk. The current meta-analysis firstly provides evidence that the MTHFR C677T polymorphism may modify the risk for brain tumors, particularly meningioma. The role of the MTHFR C677T variant in brain tumor pathogenesis across diverse ethnicities needs further elucidation by more future studies with large sample size.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23846816     DOI: 10.1007/s13277-013-0922-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  42 in total

Review 1.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

Review 2.  DNA methylation and gene silencing in cancer.

Authors:  Stephen B Baylin
Journal:  Nat Clin Pract Oncol       Date:  2005-12

3.  MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.

Authors:  Jian Zhang; Li-Xin Qiu; Zhong-Hua Wang; Xiang-Hua Wu; Xiao-Jian Liu; Bi-Yun Wang; Xi-Chun Hu
Journal:  Breast Cancer Res Treat       Date:  2010-02-09       Impact factor: 4.872

4.  Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity.

Authors:  A E Stuck; L Z Rubenstein; D Wieland
Journal:  BMJ       Date:  1998-02-07

Review 5.  Genetic and modifying factors that determine the risk of brain tumors.

Authors:  Terezinha de Cresci Braga Montelli; Maria Terezinha Serrão Peraçoli; Silvia Regina Rogatto; Ramon Kaneno; Cíntia Helena Braga Montelli do Prado; Patrícia de Medeiros Cardassi Rocha
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2011-03-01

6.  Polymorphisms of folate pathway enzymes (methylenetetrahydrofolate reductase and thymidylate synthase) and their relationship with thymidylate synthase expression in human astrocytic tumors.

Authors:  Débora Menezes da Costa; Germano Paulo Venceslau de Lima; Mário Henrique Girão Faria; Silvia Helena Barem Rabenhorst
Journal:  DNA Cell Biol       Date:  2011-08-17       Impact factor: 3.311

7.  A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity.

Authors:  I Weisberg; P Tran; B Christensen; S Sibani; R Rozen
Journal:  Mol Genet Metab       Date:  1998-07       Impact factor: 4.797

8.  C677T polymorphism of methylenetetrahydrofolate reductase may contribute to cervical cancer risk in complete over-dominant model.

Authors:  Hongmei Chen; Jin Zhu
Journal:  Med Hypotheses       Date:  2013-03-13       Impact factor: 1.538

9.  Single nucleotide polymorphisms in IL-4Ra, IL-13 and STAT6 genes occurs in brain glioma.

Authors:  Zhenchao Ruan; Yao Zhao; Lili Yan; Hongyan Chen; Weiwei Fan; Juxiang Chen; Qihan Wu; Ji Qian; Tianbao Zhang; KeKe Zhou; Yin Mao; Liangfu Zhou; Yan Huang; Daru Lu
Journal:  Front Biosci (Elite Ed)       Date:  2011-01-01

10.  Folate intake and methylenetetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers for ovarian cancer risk.

Authors:  Li Zhang; Wenxin Liu; Quan Hao; Lewen Bao; Ke Wang
Journal:  Int J Mol Sci       Date:  2012-03-23       Impact factor: 6.208

View more
  7 in total

1.  Reproductive factors in relation to risk of brain tumors in women: an updated meta-analysis of 27 independent studies.

Authors:  Hailiang Zong; Hongsheng Xu; Zhongqun Geng; Chong Ma; Xing Ming; Ming Shang; Kai Li; Xiaoguang He; Hai Du; Jianping Zhao; Lei Cao
Journal:  Tumour Biol       Date:  2014-08-19

2.  An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk.

Authors:  Qiang Wu; Yanyan Peng; Xiaotao Zhao
Journal:  Mol Neurobiol       Date:  2015-08-05       Impact factor: 5.590

3.  Adult brain cancer in the U.S. black population: a Surveillance, Epidemiology, and End Results (SEER) analysis of incidence, survival, and trends.

Authors:  Abigail Gabriel; Jason Batey; Joseph Capogreco; David Kimball; Andy Walters; R Shane Tubbs; Marios Loukas
Journal:  Med Sci Monit       Date:  2014-08-25

4.  Genetic variants and increased risk of meningioma: an updated meta-analysis.

Authors:  Xiao-Yong Han; Wei Wang; Lei-Lei Wang; Xi-Rui Wang; Gang Li
Journal:  Onco Targets Ther       Date:  2017-03-28       Impact factor: 4.147

Review 5.  Folate and Its Impact on Cancer Risk.

Authors:  Renee Pieroth; Stephanie Paver; Sharon Day; Carolyn Lammersfeld
Journal:  Curr Nutr Rep       Date:  2018-09

6.  Association between miRNA polymorphisms and susceptibility to brain tumors: A meta-analysis.

Authors:  Fu'an Gao; Yuntao Zhu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

7.  Association of methionine synthase rs1801394 and methionine synthase reductase rs1805087 polymorphisms with meningioma in adults: A meta-analysis.

Authors:  Xian-Tao Zeng; Jun-Ti Lu; Xiang-Jun Tang; Hong Weng; Jie Luo
Journal:  Biomed Rep       Date:  2014-03-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.